Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease　― Post Hoc Analysis of the FMD-J Study A ―-Reference-Cited by-同舟云学术

Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease　― Post Hoc Analysis of the FMD-J Study A ―

Published:2019-04-25 Issue:5 Volume:83 Page:1064-1071
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kajikawa Masato¹,Maruhashi Tatsuya²,Kishimoto Shinji³,Matsui Shogo²,Hashimoto Haruki²,Takaeko Yuji²,Yusoff Farina Mohamad³,Kihara Yasuki²,Chayama Kazuaki⁴,Goto Chikara⁵,Noma Kensuke¹³,Nakashima Ayumu¹,Tomiyama Hirofumi⁶,Takase Bonpei⁷,Kohro Takahide⁸,Suzuki Toru⁹,Ishizu Tomoko¹⁰,Ueda Shinichiro¹¹,Yamazaki Tsutomu¹²,Furumoto Tomoo¹³,Kario Kazuomi¹⁴,Inoue Teruo¹⁵,Koba Shinji¹⁶,Watanabe Kentaro¹⁷,Takemoto Yasuhiko¹⁸,Hano Takuzo¹⁹,Sata Masataka²⁰,Ishibashi Yutaka²¹,Node Koichi²²,Maemura Koji²³,Ohya Yusuke²⁴,Furukawa Taiji²⁵,Ito Hiroshi²⁶,Ikeda Hisao²⁷,Yamashina Akira⁶,Higashi Yukihito¹³

Affiliation:

1. Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital

2. Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University

3. Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University

4. Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University

5. Department of Physical Therapy, Hiroshima International University

6. Department of Cardiology, Tokyo Medical University

7. Division of Biomedical Engineering, National Defense Medical College Research Institute

8. Department of Clinical Informatics, Jichi Medical University School of Medicine

9. Cardiovascular Medicine, University of Leicester

10. Cardiovascular Division, Institute of Clinical Medicine, University of Tsukuba

11. Department of Clinical Pharmacology and Therapeutics, University of the Ryukyu School of Medicine

12. Department of Clinical Epidemiology and Systems, Faculty of Medicine, The University of Tokyo

13. Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

14. Division of Cardiovascular Medicine, Jichi Medical University School of Medicine

15. Department of Cardiovascular Medicine, Dokkyo Medical University

16. Department of Medicine, Division of Cardiology, Showa University School of Medicine

17. Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology (DNHMED), Yamagata University School of Medicine

18. Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine

19. Department of Medical Education and Population-based Medicine, Postgraduate School of Medicine, Wakayama Medical University

20. Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School

21. Department of General Medicine, Shimane University Faculty of Medicine

22. Department of Cardiovascular and Renal Medicine, Saga University

23. Department of Cardiovascular Medicine, Course of Medical and Dental Sciences, Graduate School of Biomedical Sciences, Nagasaki University

24. The Third Department of Internal Medicine, University of the Ryukyus

25. Department of Internal Medicine, Teikyo University School of Medicine

26. Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

27. Faculty of Fukuoka Medical Technology, Teikyo University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/5/83_CJ-18-1082/_pdf

Reference35 articles.

1. 1. Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb 2018; 25: 846–984.

2. 2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.

3. 3. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(Suppl 2): S1–S45.

4. 4. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al; Authors/Task Force Members; Additional Contributor. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016; 37: 2999–3058.

5. 6. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014; 384: 626–635.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Levels of IgM Recognizing 4-Hydroxy-2-Nonenal-Modified Apolipoprotein A-I Peptide and Its Association with the Severity of Coronary Artery Disease in Taiwanese Patients;Current Issues in Molecular Biology;2024-06-20

2. Effect of beinaglutide combined with metformin versus aspart 30 with metformin on metabolic profiles and antidrug antibodies in patients with type 2 diabetes: a randomized clinical trial;Frontiers in Endocrinology;2023-12-06

3. Vascular function: a key player in hypertension;Hypertension Research;2023-06-27

4. Association of Multitrajectories of Lipid Indices With Premature Cardiovascular Disease: A Cohort Study;Journal of the American Heart Association;2023-05-02

5. Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment;Journal of Atherosclerosis and Thrombosis;2023